Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Elysee Development (PK) Charts. Click Here for more Elysee Development (PK) Charts.](/p.php?pid=staticchart&s=NO%5EASXSF&p=8&t=15)
Remedent, Inc. (OTCBB: REMI), an international company specializing
in the research, development, manufacturing of oral care and cosmetic
dentistry products, today announced that it has signed three new
distribution agreements with Den-Mat Holdings adding to its existing
relationship:
? First, the distribution of Remedent’s Haptic Arm, that will enable
Den-Mat to tap into Remedent’s veneer design software and its haptic
design arm technology. Haptic technology relates to the technology that
interfaces with the user through the sense of touch allowing the user to
very sensitively control force and movement by applying the appropriate
feedback to the user.
? Second, an OEM branded agreement for Remedent’s teeth sensitivity
product (Remesense) whereby Den-Mat will distribute the product to the
U.S. marketplace under the name Lumisense.
? Third, the U.S. distribution of a new tray-based foam product,
Lumiboost, for the maintenance of veneers sold by Den-Mat. This product
was successfully launched during the Destination
Education event held in Las Vegas on the weekend of November 7-9th.
Financial details of these agreements have not been disclosed.
Remedent is pleased to announce that it has completed the required
training for Den-Mat personnel at Den-Mat’s facility as set forth in the
original distribution agreement announced on August 25, 2008 thereby
releasing two payments of $1 million to Remedent.
Additionally, Remedent will participate with the Denmat management team
in the training of 30 of Denmat’s key dentists, opinion leaders and
educators. Dr. Evelyne Jacquemyns of Remedent will be on hand to support
the effort. Additional LumiTray training seminars have been scheduled
for December during which month Remedent also expects to begin
manufacturing LumiTrays for Den-Mat.
Conference call
The management team of Remedent will conduct a conference call to
discuss its financial results for the second quarter ended September 30,
2008 and updated developments on Thursday, November 20th at
11:00 am ET. Interested parties in the U.S. may participate in the call
by dialing (877) 407-8037; callers outside the U.S. may participate by
dialing (201) 689-8037 about 5-10 minutes prior to 11:00 am ET. The
conference call will also be available on replay starting at 3:00 pm ET
on November 20, 2008, and ending on December 20, 2008. For the replay,
U.S. participants please dial (877) 660-6853 (replay account # 313,
replay conference # 304300). The access number for the replay for
callers outside the U.S. is (201) 612-7415 (replay account # 313, replay
conference # 304300).
About Remedent, Inc.
Remedent, Inc., a publicly-traded company on the OTCBB,
specializes in the research, development, manufacturing and marketing of
oral care and cosmetic dentistry products. With offices in California,
Belgium and Singapore, Remedent distributes its products in more than 35
countries. For additional information, visit Remedent's web site at www.remedent.com.